EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis

Rownaq Fares Al-Sofi, Mie Siewertsen Bergmann iD, Claus Henrik Nielsen iD, Vibeke Andersen, Lone Skov iD, Nikolai Loft iD

International Journal of Molecular Sciences · 26.05.2024 · 25 (11) · 5793

DOI: 10.3390/ijms25115793 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.05.2024. Verfasst von Rownaq Fares Al-Sofi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, 1165 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Psoriasis, Polymorphism, Single Nucleotide, Biological Products. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic biomarkers could potentially lower the risk of treatment failure in chronic inflammatory diseases (CID) like psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA), and inflammatory bowel disease (IBD). We performed a systematic review and meta-analysis assessing the association between single nucleotide polymorphisms (SNPs) and response to biologics. Odds ratio (OR) with 95% confidence interval (CI) meta-analyses were performed. In total, 185 studies examining 62,774 individuals were included. For the diseases combined, the minor allele of MYD88 (rs7744) was associated with good response to TNFi (OR: 1.24 [1.02–1.51], 6 studies, 3158 patients with psoriasis or RA) and the minor alleles of NLRP3 (rs4612666) (OR: 0.71 [0.58–0.87], 5 studies, 3819 patients with RA or IBD), TNF-308 (rs1800629) (OR: 0.71 [0.55–0.92], 25 studies, 4341 patients with psoriasis, RA, or IBD), FCGR3A (rs396991) (OR: 0.77 [0.65–0.93], 18 studies, 2562 patients with psoriasis, PsA, RA, or IBD), and TNF-238 (rs361525) (OR: 0.57 [0.34–0.96]), 7 studies, 818 patients with psoriasis, RA, or IBD) were associated with poor response to TNFi together or infliximab alone. Genetic variants in TNFα, NLRP3, MYD88, and FcRγ genes are associated with response to TNFi across several inflammatory diseases. Most other genetic variants associated with response were observed in a few studies, and further validation is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesPsoriasisPolymorphism, Single NucleotideBiological ProductsArthritis, RheumatoidArthritis, PsoriaticHumansNLR Family, Pyrin Domain-Containing 3 ProteinMyeloid Differentiation Factor 88

Stichwörter der Autor:innen

Crohnsbiomarkersinflammatory bowel diseasespharmacogeneticspsoriasispsoriatic arthritisrheumatoid arthrititsulcerative colitis

Substanzen

Biological ProductsNLR Family, Pyrin Domain-Containing 3 ProteinMyeloid Differentiation Factor 88

Autor:innen und Institutionen

  • Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, 1165 Copenhagen, Denmark.
  • Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.
  • Center for Rheumatology and Spine Diseases, Institute for Inflammation Research, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark.
  • Institute of Regional Health Research, University of Southern Denmark, 5230 Odense, Denmark.
  • Molecular Diagnostics and Clinical Research Unit, Department of Internal Medicine, University Hospital of Southern Denmark, 6200 Aabenraa, Denmark.
  • Institute of Molecular Medicine, University of Southern Denmark, 5230 Odense, Denmark.

ORCID-Profile: Mie Siewertsen Bergmann, Claus Henrik Nielsen, Lone Skov, Nikolai Loft

Zitieren

APA

Al-Sofi, R. F., Bergmann, M. S., Nielsen, C. H., Andersen, V., Skov, L., & Loft, N. (2024). The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 25(11), 5793. https://doi.org/10.3390/ijms25115793

Vancouver

Al-Sofi RF, Bergmann MS, Nielsen CH, Andersen V, Skov L, Loft N. The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2024;25(11):5793. doi:10.3390/ijms25115793

BibTeX
@article{AlSofi2024,
  author = {Al-Sofi, Rownaq Fares and Bergmann, Mie Siewertsen and Nielsen, Claus Henrik and Andersen, Vibeke and Skov, Lone and Loft, Nikolai},
  title = {The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {11},
  pages = {5793},
  doi = {10.3390/ijms25115793}
}
Kostenlos starten →